Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07312305
Eligibility Criteria:
Inclusion Criteria:
* Age over 18 years
* IPF of any degree of severity, diagnosed according to the 2022 ATS/ERS/JRS/ALAT guidelines
Exclusion Criteria:
* Refusal to participate in the study
* Patients unable to provide informed consent for participation in the study
* IPF exacerbation in the 6 months prior to enrollment
* Previous diagnosis of chronic airway disease (e.g., bronchial asthma, chronic obstructive bronchitis, bronchiectasis with a cause other than IPF)
* Presence of bronchial obstruction defined by an FEV1/FVC (or FEV1/VC) ratio below the lower limit of normal
* Chronic therapy with long-acting bronchodilators or combinations of bronchodilators and inhaled corticosteroids
* Inability of the patient to perform reproducible pulmonary function tests
* Chronic treatment with systemic corticosteroids or immunosuppressants
* Concomitant lung or pleural cancer
* Pregnancy or breastfeeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07312305
Study Brief:
Protocol Section:
NCT07312305